What percentage of individuals with bipolar disorder develop dementia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Dementia in Bipolar Disorder

Individuals with bipolar disorder have approximately 2.36 times higher risk of developing dementia compared to the general population. 1

Epidemiology and Risk Factors

Bipolar disorder significantly increases the risk of developing dementia later in life. This association is supported by robust evidence from systematic reviews and meta-analyses. The increased risk appears to be substantial:

  • Meta-analysis data shows bipolar disorder increases dementia risk by 136% (odds ratio: 2.36) 1
  • Approximately 25% of individuals with bipolar disorder may develop dementia during long-term follow-up 2
  • Alzheimer's disease appears to be the most common dementia subtype in bipolar patients, though this finding may be influenced by sampling biases 2

Mechanisms and Clinical Manifestations

The relationship between bipolar disorder and dementia involves several potential mechanisms:

  • Cognitive decline in bipolar disorder patients who develop dementia can be detected approximately 2 years before formal dementia diagnosis 2

  • Early warning signs include declining performance in:

    • Verbal memory
    • Language function (particularly verbal fluency)
    • Speeded attention tasks 2
  • Normal cognitive aging in bipolar disorder is generally stable, so marked decline in verbal episodic memory or semantic retrieval may indicate an early neurodegenerative process 2

Treatment Considerations and Impact on Dementia Risk

Medication choices in bipolar disorder may significantly influence dementia risk:

  • Valproic acid treatment increases dementia risk: Studies show valproic acid therapy in bipolar disorder patients increases dementia risk by 73-95% compared to non-valproic acid treated patients 3

  • Lithium may be protective: Lithium therapy appears to reduce Alzheimer's disease prevalence in elderly bipolar patients to levels comparable to the general population (5% in lithium-treated vs. 33% in non-lithium treated) 4

Clinical Implications

For clinicians managing bipolar disorder patients:

  1. Monitor cognitive function regularly, especially in older patients

  2. Be alert to early signs of cognitive decline that may indicate prodromal dementia:

    • Declining verbal memory
    • Reduced verbal fluency
    • Slowed processing speed
  3. Consider medication impact on dementia risk:

    • Lithium may offer neuroprotective benefits
    • Valproic acid may increase dementia risk
    • Medication choices should weigh mood stabilization benefits against potential cognitive impacts
  4. Educate patients and families about the increased dementia risk associated with bipolar disorder

Conclusion

The evidence clearly demonstrates that bipolar disorder significantly increases dementia risk. Clinicians should be vigilant for early signs of cognitive decline in bipolar patients, particularly in verbal memory and language domains. Medication choices, especially between lithium and valproic acid, may substantially influence long-term dementia outcomes in this population.

References

Research

History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2017

Research

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder.

The British journal of psychiatry : the journal of mental science, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.